Huntington's disease is an inherited disorder caused by expanded stretch of consecutive trinucleotides (cytosine– adenosine–guanine, CAG) within the first exon of the huntingtin (HTT) gene on chromosome 4 (p16.3). Themutated huntingtin (mHTT) gains toxic function, probably through mechanisms that involve aberrant interactions in several pathways, causing cytotoxicity. Pathophysiology of disease involves several tissues; indeed it has been shown that there is a broad toxic effect of mHTT in the peripheral tissue of patients with HD, not only in the central nervous system. In this study we compared gene expression profiles (GEP) of HD fibroblasts and matched controls using microarray technology. We used RT-PCR to test the consistency of the microarray data and we found four genes up-regulated in HD patients with respect to control individuals. The genes appear to be involved in different pathways that have been shown to be perturbed even in HDmodels and patients. Although our study is preliminary and has to be extended to a larger cohort of HD patients and controls, nevertheless it shows that gene expression profiles seem to be altered in the fibroblasts of HD patients. Validation of the differential expressions at the protein level is required to ascertain if this cell type can be considered a suitable model for the identification of HD biomarkers

Gene expression profile in fibroblasts of Huntington's disease patients and controls.

MARCHINA, Eleonora;MISASI, Silvia;BOZZATO, Andrea;FERRABOLI, Sergio;AGOSTI, CHIARA;ROZZINI, Luca;BORSANI, Giuseppe;BARLATI, Sergio;PADOVANI, Alessandro
2014-01-01

Abstract

Huntington's disease is an inherited disorder caused by expanded stretch of consecutive trinucleotides (cytosine– adenosine–guanine, CAG) within the first exon of the huntingtin (HTT) gene on chromosome 4 (p16.3). Themutated huntingtin (mHTT) gains toxic function, probably through mechanisms that involve aberrant interactions in several pathways, causing cytotoxicity. Pathophysiology of disease involves several tissues; indeed it has been shown that there is a broad toxic effect of mHTT in the peripheral tissue of patients with HD, not only in the central nervous system. In this study we compared gene expression profiles (GEP) of HD fibroblasts and matched controls using microarray technology. We used RT-PCR to test the consistency of the microarray data and we found four genes up-regulated in HD patients with respect to control individuals. The genes appear to be involved in different pathways that have been shown to be perturbed even in HDmodels and patients. Although our study is preliminary and has to be extended to a larger cohort of HD patients and controls, nevertheless it shows that gene expression profiles seem to be altered in the fibroblasts of HD patients. Validation of the differential expressions at the protein level is required to ascertain if this cell type can be considered a suitable model for the identification of HD biomarkers
File in questo prodotto:
File Dimensione Formato  
JNS12916.pdf

gestori archivio

Tipologia: Full Text
Licenza: DRM non definito
Dimensione 354.75 kB
Formato Adobe PDF
354.75 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11379/339909
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 20
social impact